<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Many studies have indicated low serum antioxidant levels and insulin resistance in PCOS women [
 <xref rid="B46-biomolecules-09-00215" ref-type="bibr" class="xref">46</xref>,
 <xref rid="B47-biomolecules-09-00215" ref-type="bibr" class="xref">47</xref>,
 <xref rid="B48-biomolecules-09-00215" ref-type="bibr" class="xref">48</xref>]. In fact, hyperglycemia can enhance OS through numerous pathways. However, through a major non-enzymatic mechanism, it induces the intracellular ROS, generates electrochemical proton gradient produced by mitochondrial electron transport chain (mETC), and results in enhanced derivation of superoxide [
 <xref rid="B49-biomolecules-09-00215" ref-type="bibr" class="xref">49</xref>]. In addition, reactive species by impairing glucose uptake in muscle and fat [
 <xref rid="B50-biomolecules-09-00215" ref-type="bibr" class="xref">50</xref>], and also by reducing insulin secretion from pancreatic β cells play a crucial role in insulin resistance [
 <xref rid="B7-biomolecules-09-00215" ref-type="bibr" class="xref">7</xref>]. On the other hand, an imbalance between oxidant-antioxidant is responsible for ovarian disturbance, insulin resistance, and chronic inflammation that is associated with pancreatic β cell dysfunction in women with PCOS [
 <xref rid="B10-biomolecules-09-00215" ref-type="bibr" class="xref">10</xref>]. Although ROS and RNS at low concentrations play physiological roles in cellular signaling pathways, in excess levels they may damage cellular functions [
 <xref rid="B6-biomolecules-09-00215" ref-type="bibr" class="xref">6</xref>]. Reactive oxygen species react with lipids, causing them to boost peroxidation products such as MDA [
 <xref rid="B47-biomolecules-09-00215" ref-type="bibr" class="xref">47</xref>].
</p>
